FEB 16, 2017 3:06 PM PST

New Malaria Vaccine Conferred Total Immunity in Small Trial

WRITTEN BY: Xuan Pham

Recently, there’s been loud grumblings about a potential malaria vaccine, but a truly effective vaccine remained elusive. Indeed, producing an effective vaccine against a parasite has proven tougher than that against a virus. But this may all change, as researchers at Sanaria, a biotech company, just boldly announced the success of a malaria vaccine that’s 100 percent effective in a small human clinical trial. This may be the closest we’ve ever gotten to a real and feasible malaria vaccine.

Malaria remains one of the biggest public health problems worldwide. Nearly half the world’s population, or over 3 billion people are at risk of malaria infection, which can cause fever, fatigue, bleeding, seizure, and even death. Although the World Health Organization reports death rates from malaria are dropping, the disease still claimed nearly 438,000 deaths in 2015.

"Scientists have been trying to develop a highly effective malaria vaccine for more than a century with thousands of scientists working on it, billions of dollars have been spent and to date there's no licenced malaria vaccine," said Stephen Hoffman, a scientist at Sanaria.

Previous malaria vaccines proved to be ineffective because they only contained pieces of, or a weakened form of the Plasmodium parasite. So Sanaria’s approach was to go big or go home.

The vaccine Sanaria created is based on live Plasmodium sporozoites – the version of the parasite that elicits an immune response in people. In what seemed like mad science, the researchers injected the live sporozoites into volunteers. The volunteers also received antimalarial pills (chloroquine) before, during and after the injections.

Ten weeks later, in people who received the vaccination, exposure to the sporozoites elicited no immune response, suggesting these people had been immunized. By contrast, people who didn’t receive the injections had evidence of the parasite in their blood.

"The lower dose group had 33 per cent protection, the middle group had 67 per cent protection and the higher group had nine out of nine (100 per cent)," Hoffman explained.

Total immunity in human volunteers is something only one other team has been able to claim, and it was also with the help of live sporozoites. In 2009, researchers found similar immunity success through direct mosquito bites.

"Previous efforts have used mosquitoes to deliver live [sporozoites]," but as Hoffman points out, this method is crude and impractical. "You can't have a mosquito come to a doctor's office to immunize you or vaccinate you".

Indeed, "the advance here is that this can be achieved by intravenous injection of a purified population of sporozoites rather than requiring the vaccinated person to be bitten by many hundreds or thousands of infected mosquitoes,” commented Eleanor Riley, a disease immunology expert at the London School of Hygiene and Tropical Medicine. Riley was not associated with the current research.

Despite the limitations of the experiment, including the small trial size and duration, the results represent a huge milestone for malaria vaccine development.

“This is a first step,” says Hoffman. “We still have a lot of work cut out for us. But we believe that this kind of approach can be used to immunize the entire population, so we can halt transmission of the parasite and eliminate it geographically from systematically defined areas.”

Additional sources: Popular Science, Wired, Science

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 11, 2019
Clinical & Molecular DX
JUL 11, 2019
Difficulties With Diagnosing Lyme Disease
Now found in 65 countries worldwide, Lyme disease is the fastest-growing vector-borne illness in the United States. Recent estimates suggest approximately ...
JUL 20, 2019
Clinical & Molecular DX
JUL 20, 2019
Diagnosing Autism, The Child-Friendly Way
The term autism spectrum disorder ASD is an umbrella term for a wide range of conditions. These conditions are characterized by difficulty in social situat...
AUG 13, 2019
Health & Medicine
AUG 13, 2019
Blood-Brain Barrier Impairment and Its Role in Alzheimer's Disease
In healthy people, the blood-brain barrier (BBB), which is fromed by brain endothelial cells, strictly controls the entrance of harmful materials into...
OCT 09, 2019
Neuroscience
OCT 09, 2019
Elderly Depression Remains Consistant As Antidepressant Use Doubles
  A new study from the University of East Anglia finds that despite a 2-fold increase in antidepressant use, depression among individuals 65 and older...
OCT 18, 2019
Health & Medicine
OCT 18, 2019
Are Washing Machines a Reservoir for Multidrug Resistant Pathogens?
Multidrug-resistant bacteria are frequently found in hospitals and long-term nursing facilities causing one of the largest public health concerns worldwide...
JAN 13, 2020
Chemistry & Physics
JAN 13, 2020
Magnetic Field-guided Tethered-probe Can Navigate Complex Vascular Networks
Deep and complex vasculatures such as carotid arteries represent a challenge for diagnosis and treatment because they are buried underneath layers of other...
Loading Comments...